BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 288114)

  • 1. [Rifampicin: laboratory study on Gram negative bacteria and Staphylococcus aureus].
    Silva J; Zemelman R; Angélica Mondaca M
    Rev Latinoam Microbiol; 1978; 20(2):69-73. PubMed ID: 288114
    [No Abstract]   [Full Text] [Related]  

  • 2. The susceptibility of bacteroides, fusobacterium leptotrichia, and sphaerophorus strains to rifampicin.
    Werner H
    Arzneimittelforschung; 1972 Jun; 22(6):1043-5. PubMed ID: 5068353
    [No Abstract]   [Full Text] [Related]  

  • 3. [In vitro sensitivity of Staphylococcus and gram negative bacteria to rifampicin].
    Ales Reinlein AM; Fernández Puentes MC; Torres Cid A
    Rev Clin Esp; 1973 Jul; 130(2):99-102. PubMed ID: 4742347
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequencies of resistance to Melaleuca alternifolia (tea tree) oil and rifampicin in Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.
    Hammer KA; Carson CF; Riley TV
    Int J Antimicrob Agents; 2008 Aug; 32(2):170-3. PubMed ID: 18571379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Nosocomial catheter-related sepsis secondary to central venous catheters].
    Wu H; Wu Z; Jin D; Xu J
    Zhonghua Wai Ke Za Zhi; 1999 Nov; 37(11):651-3. PubMed ID: 11829916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Sensitivity of methicillin resistant staphylococci to linezolid and some other antimicrobial agents].
    Ertek M; Yazgi H; Aktaş E; Ayyildiz A; Parlak M
    Mikrobiyol Bul; 2003 Oct; 37(4):235-40. PubMed ID: 14748259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistance development in community-acquired strains of methicillin-resistant Staphylococcus aureus: an in vitro study.
    Munckhof WJ; Kleinschmidt SL; Turnidge JD
    Int J Antimicrob Agents; 2004 Dec; 24(6):605-8. PubMed ID: 15555885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro antimicrobial activity of CI-919 against gram-negative bacilli and Staphylococcus aureus isolated from various pathologies].
    Prado V; Reyes L
    Rev Med Chil; 1985 Feb; 113(2):94-102. PubMed ID: 3866270
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antibacterial activity of rifampicin against the causative agents of suppurative, septic diseases].
    Samoĭlova LN; Fomina IP; Bodunkova LE
    Antibiotiki; 1977 Jan; 22(1):46-50. PubMed ID: 402885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative post-antibiotic effect of five antibiotics against ten aerobic gram-positive cocci.
    Drabu YJ; Blakemore PH
    Drugs Exp Clin Res; 1990; 16(11):557-63. PubMed ID: 2151661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of quinupristin/dalfopristin versus vancomycin, alone or in combination with rifampicin, against methicillin-resistant Staphylococcus aureus in a rabbit arthritis model.
    Hamel A; Caillon J; Jacqueline C; Batard E; Potel G
    Int J Antimicrob Agents; 2008 Feb; 31(2):158-60. PubMed ID: 18006281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Decrease in the physiological sensitivity to rifampicin in Staphylococcus aureus growing in tissue inside phagocytes and outside the cells].
    Pavlov EP; Tushov EG
    Antibiotiki; 1974 Nov; 19(11):966-9. PubMed ID: 4617561
    [No Abstract]   [Full Text] [Related]  

  • 13. In vitro activity against aerobes and anaerobes of trospectomycin versus spectinomycin.
    Gismondo MR; Chisari G; Lo Bue AM
    Drugs Exp Clin Res; 1991; 17(2):101-4. PubMed ID: 1830841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: evidence of resistance to vancomycin.
    Burnie J; Matthews R; Jiman-Fatami A; Gottardello P; Hodgetts S; D'arcy S
    Clin Infect Dis; 2000 Sep; 31(3):684-9. PubMed ID: 11017816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Distribution of pathogen and resistance of nosocomial infections in the intensive care units].
    Dai CM; Zhou JD; Wu Y; Qi Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Apr; 31(2):277-80. PubMed ID: 16706133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative in vitro activity of imipenem against gram-positive and gram-negative aerobic bacteria from clinical isolates.
    Bastianini L; Sposini T; Bartoli A; Marconi P
    Microbiologica; 1988 Apr; 11(2):137-42. PubMed ID: 3165489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selection of rifampicin-resistant Staphylococcus aureus during tuberculosis therapy: concurrent bacterial eradication and acquisition of resistance.
    Liu Y; Cui J; Wang R; Wang X; Drlica K; Zhao X
    J Antimicrob Chemother; 2005 Dec; 56(6):1172-5. PubMed ID: 16207765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vitro susceptibility to aztreonam.
    Lim VK
    Malays J Pathol; 1988 Aug; 10():61-4. PubMed ID: 3252078
    [No Abstract]   [Full Text] [Related]  

  • 19. An antimicrobial modified silicone peritoneal catheter with activity against both Gram-positive and Gram-negative bacteria.
    Bayston R; Fisher LE; Weber K
    Biomaterials; 2009 Jun; 30(18):3167-73. PubMed ID: 19289248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Criteria for the selection of antibiotics in the empirical therapy of gram negative infections].
    Betts RF
    Internist (Berl); 1981 Nov; 22(11):710-4. PubMed ID: 7031008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.